| C569107 | 1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one | "1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one affects the expression of CDKN1B protein" | 21903591 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [CDK2 protein binds to CCNA2 protein binds to CDKN1B protein]" | 20637255 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [CDK2 protein binds to CCNE1 protein binds to CDKN1B protein]" | 20637255 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of CDKN1B protein" | 20637255 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "Tetrachlorodibenzodioxin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [CDK2 protein binds to CCNA2 protein binds to CDKN1B protein]]" | 20637255 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "[Tetrachlorodibenzodioxin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [CDK2 protein binds to CCNA2 protein binds to CDKN1B protein]]] which results in decreased activity of CDK2 protein" | 20637255 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "Tetrachlorodibenzodioxin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [CDK2 protein binds to CCNE1 protein binds to CDKN1B protein]]" | 20637255 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "[Tetrachlorodibenzodioxin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [CDK2 protein binds to CCNE1 protein binds to CDKN1B protein]]] which results in decreased activity of CDK2 protein" | 20637255 |
| C495626 | 14-deoxy-11,12-didehydroandrographolide | "14-deoxy-11,12-didehydroandrographolide results in increased expression of CDKN1B mRNA" | 22101062 |
| C074153 | 1,4-phenylenebis(methylene)selenocyanate | "1,4-phenylenebis(methylene)selenocyanate results in increased expression of CDKN1B mRNA" | 12844480 |
| C477941 | 1,4-phenylenebis(methylene)selenocyanate, glutathione conjugate | "1,4-phenylenebis(methylene)selenocyanate, glutathione conjugate results in increased expression of CDKN1B mRNA" | 12844480 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of CDKN1B protein" | 15729575 |
| C448659 | 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin | 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin results in increased expression of CDKN1B protein | 19440035 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [sorafenib results in increased expression of CDKN1B protein]" | 23036488 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [U 0126 results in increased expression of CDKN1B protein]" | 22101421 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased expression of CDKN1B protein" | 22101421|2303648 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "[OGT mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which affects the expression of CDKN1B protein" | 23029544 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "[PIK3CA gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in increased expression of CDKN1B mRNA" | 20453058 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "[PIK3CA gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in increased expression of CDKN1B protein" | 20453058 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "sorafenib promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased expression of CDKN1B protein]" | 23036488 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "[U 0126 co-treated with 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] results in increased expression of CDKN1B protein" | 22101421 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "U 0126 promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased expression of CDKN1B protein]" | 22101421 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether affects the expression of CDKN1B mRNA" | 26988655 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased degradation of CDKN1B protein] | 17283133 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of CDKN1B protein | 17513607 |
| C546571 | 2,2'-cyclohexane-1,2-diylbis(azanediyl)bis(methylene)diphenoldichloroplatinum(II) | "2,2'-cyclohexane-1,2-diylbis(azanediyl)bis(methylene)diphenoldichloroplatinum(II) results in decreased expression of CDKN1B mRNA" | 19694485 |
| C587734 | 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | "2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of CDKN1B protein" | 26451628 |
| C078765 | 2,3,5-(triglutathion-S-yl)hydroquinone | "2,3,5-(triglutathion-S-yl)hydroquinone affects the localization of and results in increased expression of CDKN1B protein" | 21693435 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of CDKN1B protein | 11322924|1714867 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [decitabine co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Sirolimus] results in increased expression of CDKN1B mRNA | 18622747 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [resveratrol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased expression of CDKN1B protein | 21179458 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of CDKN1B protein | 15601625 |
| C089946 | 2,4-thiazolidinedione | "2,4-thiazolidinedione results in increased expression of CDKN1B protein" | 15916743 |
| C007997 | 25-hydroxycholesterol | 25-hydroxycholesterol results in increased expression of CDKN1B mRNA | 17161435 |
| C035208 | 2-amino-4,6-dinitrotoluene | "2-amino-4,6-dinitrotoluene results in increased expression of CDKN1B mRNA" | 26251320 |
| C570662 | 2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one | "2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one results in increased expression of CDKN1B protein" | 23639247 |
| C457499 | 2-chloro-5-nitrobenzanilide | "2-chloro-5-nitrobenzanilide inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased expression of CDKN1B protein]" | 28834734 |
| C522458 | 2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic acid | "2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic acid results in increased expression of CDKN1B protein" | 17475810 |
| C022830 | 2-methoxyestradiol | 2-methoxyestradiol results in increased expression of CDKN1B protein | 23967052 |
| C511621 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] | 24013123 |
| C016392 | 3,3'-diindolylmethane | "3,3'-diindolylmethane results in increased expression of CDKN1B protein" | 22290291 |
| C513485 | (3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester | "(3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester analog results in increased expression of CDKN1B protein" | 16039525 |
| C513485 | (3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester | "(3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester results in increased expression of CDKN1B protein" | 16039525 |
| C478100 | 3,4-di-O-caffeoylquinic acid | "3,4-di-O-caffeoylquinic acid results in increased expression of CDKN1B protein" | 21872580 |
| C494914 | 3,5,3',4',5'-pentamethoxystilbene | "3,5,3',4',5'-pentamethoxystilbene results in increased expression of CDKN1B mRNA" | 19916542 |
| C494914 | 3,5,3',4',5'-pentamethoxystilbene | "3,5,3',4',5'-pentamethoxystilbene results in increased expression of CDKN1B protein" | 19916542 |
| C091768 | 3'-methoxy-4'-nitroflavone | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] | 24013123 |
| C581004 | 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile | "2-chloro-5-nitrobenzanilide inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased expression of CDKN1B protein]" | 28834734 |
| C581004 | 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile | "3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased expression of CDKN1B protein" | 28834734 |
| C581004 | 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile | "3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased expression of CDKN1B protein" | 28834734 |
| C038864 | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | "4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in decreased expression of CDKN1B protein]" | 11348869 |
| C038864 | 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid | "4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased stability of CDKN1B protein" | 11348869 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1B protein] | 18805435 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Nicotine results in decreased expression of CDKN1B protein] | 18805435 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein] | 16322342 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | [zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein | 16322342 |
| C116322 | 4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine | 4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine results in decreased expression of CDKN1B mRNA | 21352547 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1B protein] | 18805435 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1B protein | 18805435 |
| C041594 | 4-nonylphenol | 4-nonylphenol results in decreased expression of CDKN1B mRNA | 26804032 |
| C041594 | 4-nonylphenol | 4-nonylphenol results in increased expression of CDKN1B protein | 26804764 |
| C012606 | 4-vinyl-1-cyclohexene dioxide | 4-vinyl-1-cyclohexene dioxide affects the expression of CDKN1B mRNA | 20829426 |
| C573233 | 5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one | "5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in decreased expression of CDKN1B protein]" | 24646949 |
| C034214 | 5-iodotubercidin | 5-iodotubercidin results in decreased phosphorylation of CDKN1B protein | 26953159 |
| C580598 | 5-OH-BDE-47 | 5-OH-BDE-47 results in decreased expression of CDKN1B mRNA | 26988655 |
| C107875 | 6-(methylamino)pyrido(3,4-d)pyrimidine | "6-(methylamino)pyrido(3,4-d)pyrimidine results in increased expression of CDKN1B protein" | 15572027 |
| C531937 | 6-O-angeloylenolin | 6-O-angeloylenolin results in decreased expression of CDKN1B protein | 21192922 |
| C025724 | 9-methoxycamptothecin | 9-methoxycamptothecin results in increased expression of CDKN1B mRNA | 23369935 |
| C025724 | 9-methoxycamptothecin | 9-methoxycamptothecin results in increased expression of CDKN1B protein | 23369935 |
| C503142 | ABT-100 | ABT-100 results in decreased phosphorylation of CDKN1B protein | 15930366 |
| C503142 | ABT-100 | ABT-100 results in increased expression of CDKN1B protein | 15930366 |
| C542662 | AC 93253 | AC 93253 results in decreased expression of CDKN1B mRNA | 25912555 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CDKN1B mRNA | 16701773 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein] | 18022818 |
| D000111 | Acetylcysteine | Acetylcysteine promotes the reaction [AHR protein binds to CDKN1B enhancer] | 18022818 |
| D000111 | Acetylcysteine | Acetylcysteine results in increased expression of CDKN1B protein | 17602960 |
| D000111 | Acetylcysteine | Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of CDKN1B protein] | 17602960 |
| D000171 | Acrolein | [ferric oxide analog co-treated with Acrolein] results in decreased expression of CDKN1B protein | 24847785 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of CDKN1B protein | 20734998 |
| C058956 | acteoside | acteoside promotes the reaction [CDKN1B protein binds to CDK4 protein] | 17634406 |
| C058956 | acteoside | acteoside promotes the reaction [CDKN1B protein binds to CDK6 protein] | 17634406 |
| C058956 | acteoside | acteoside results in increased expression of CDKN1B mRNA | 17634406 |
| C058956 | acteoside | acteoside results in increased expression of CDKN1B protein | 17634406 |
| D000242 | Cyclic AMP | [Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein | 21693435 |
| D000242 | Cyclic AMP | [Pentoxifylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein | 21693435 |
| D000242 | Cyclic AMP | sorafenib inhibits the reaction [[Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein] | 21693435 |
| D000242 | Cyclic AMP | [Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein | 21693435 |
| C016601 | afimoxifene | [afimoxifene co-treated with lapatinib] promotes the reaction [CDKN1B protein binds to and results in decreased activity of [CCNE1 protein binds to CDK2 protein]] | 15665275 |
| C016601 | afimoxifene | [afimoxifene co-treated with lapatinib] results in increased expression of CDKN1B protein | 15665275 |
| C016601 | afimoxifene | afimoxifene promotes the reaction [CDKN1B protein binds to and results in decreased activity of [CCNE1 protein binds to CDK2 protein]] | 15665275 |
| C016601 | afimoxifene | afimoxifene results in increased expression of CDKN1B protein | 15665275 |
| C016601 | afimoxifene | afimoxifene results in increased expression of CDKN1B mRNA | 17640349 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of CDKN1B gene | 27153756 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [CDKN1B protein binds to SRC protein] | 28215542 |
| C430898 | AGN 194204 | AGN 194204 inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in decreased expression of CDKN1B protein] | 11348869 |
| C430898 | AGN 194204 | AGN 194204 results in increased stability of CDKN1B protein | 11348869 |
| C103303 | alitretinoin | alitretinoin inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in decreased expression of CDKN1B protein] | 11348869 |
| C103303 | alitretinoin | alitretinoin results in increased expression of CDKN1B protein | 16340750 |
| C103303 | alitretinoin | alitretinoin results in increased stability of CDKN1B protein | 11348869 |
| C103303 | alitretinoin | seocalcitol inhibits the reaction [alitretinoin results in increased expression of CDKN1B protein] | 16340750 |
| C002055 | allose | allose results in increased expression of CDKN1B protein | 18930000 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone inhibits the reaction [[Curcumin co-treated with Quercetin] results in increased expression of CDKN1B protein] | 27132804 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone results in decreased expression of CDKN1B mRNA | 26804032 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein] | 22266097 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] | 15157999 |
| C077990 | alvocidib | alvocidib results in increased cleavage of CDKN1B protein | 10537362 |
| C077990 | alvocidib | alvocidib results in increased expression of CDKN1B protein | 12589031|1518095 |
| C077990 | alvocidib | [alvocidib results in increased expression of TP53 protein] which results in increased expression of CDKN1B protein | 12589031 |
| C077990 | alvocidib | alvocidib results in increased expression of CDKN1B protein | 15180955 |
| C068073 | Am 580 | Am 580 affects the localization of CDKN1B protein | 16618747 |
| D000499 | Allylamine | Allylamine results in increased expression of CDKN1B protein | 15048878 |
| D000499 | Allylamine | pyrrolidine dithiocarbamic acid inhibits the reaction [Allylamine results in increased expression of CDKN1B protein] | 15048878 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CDKN1B mRNA | 16483693 |
| D000814 | Aniline Compounds | Aniline Compounds results in increased expression of CDKN1B protein | 25123791 |
| C053442 | annonacin | annonacin results in increased expression of CDKN1B protein | 21840388 |
| D000872 | Anthocyanins | Anthocyanins results in increased expression of CDKN1B protein | 27444805 |
| C102351 | apicidin | apicidin results in increased expression of CDKN1B protein | 18313654 |
| D001149 | Arsenates | [Atrazine co-treated with Arsenates] results in increased expression of CDKN1B mRNA | 18585445 |
| D001151 | Arsenic | Arsenic affects the methylation of CDKN1B gene | 25304211 |
| D001151 | Arsenic | [silybin co-treated with Arsenic] results in increased expression of CDKN1B protein | 25868784 |
| D001151 | Arsenic | Arsenic results in decreased expression of CDKN1B mRNA | 19654921 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with Curcumin] results in increased expression of CDKN1B protein | 27430728 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CDKN1B mRNA | 19769630 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of and results in increased localization of CDKN1B protein | 20698225 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CDKN1B gene | 21544632 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CDKN1B mRNA | 19236751|2045855 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CDKN1B protein | 20458559|2095313 |
| C006632 | arsenic trioxide | salvin promotes the reaction [arsenic trioxide results in increased expression of CDKN1B protein] | 23239002 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CDKN1B mRNA | 19379560 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CDKN1B protein | 19379560 |
| C015001 | arsenite | arsenite results in increased methylation of CDKN1B promoter | 23974009 |
| D001205 | Ascorbic Acid | [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA | 18544905 |
| D001241 | Aspirin | [troglitazone co-treated with Aspirin] results in increased expression of CDKN1B protein | 19908241 |
| D001241 | Aspirin | Aspirin results in increased expression of CDKN1B protein | 16880202 |
| D000069059 | Atorvastatin Calcium | [Atorvastatin Calcium co-treated with Celecoxib] results in increased expression of CDKN1B protein | 18172863 |
| D000069059 | Atorvastatin Calcium | Atorvastatin Calcium results in increased expression of CDKN1B protein | 16470222 |
| D001280 | Atrazine | [Atrazine co-treated with Arsenates] results in increased expression of CDKN1B mRNA | 18585445 |
| D001397 | Azoxymethane | Azoxymethane results in decreased expression of CDKN1B mRNA | 12189186 |
| D001397 | Azoxymethane | Azoxymethane results in decreased expression of CDKN1B protein | 12189186 |
| D001397 | Azoxymethane | Calcium Chloride inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] | 12189186 |
| D001397 | Azoxymethane | Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] | 12189186 |
| D001397 | Azoxymethane | Sulindac inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] | 12189186 |
| D001554 | Benzene | Benzene results in decreased expression of CDKN1B mRNA | 20018183 |
| D001564 | Benzo(a)pyrene | AHR affects the reaction [Benzo(a)pyrene results in increased expression of CDKN1B mRNA] | 21995607 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [AHR protein binds to CDKN1B promoter] | 21995607 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of CDKN1B mRNA | 22228805 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CDKN1B mRNA | 21995607 |
| D001564 | Benzo(a)pyrene | [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of CDKN1B mRNA | 25820237 |
| D001564 | Benzo(a)pyrene | AHR affects the reaction [Benzo(a)pyrene results in decreased expression of CDKN1B protein] | 17141280 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of CDKN1B protein | 17141280 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of CDKN1B protein | 17283133 |
| C038328 | BEP protocol | BEP protocol results in increased expression of CDKN1B mRNA | 18987330 |
| D001599 | Berberine | Berberine results in increased expression of CDKN1B protein | 16505103 |
| D004958 | Estradiol | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased degradation of CDKN1B protein] | 17283133 |
| D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in increased expression of CDKN1B mRNA | 22064387 |
| D004958 | Estradiol | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CDKN1B protein | 9705214 |
| D004958 | Estradiol | Estradiol promotes the reaction [Medroxyprogesterone Acetate results in increased expression of CDKN1B protein] | 17283133 |
| D004958 | Estradiol | Estradiol results in decreased expression of and results in increased degradation of CDKN1B protein | 23029392 |
| D004958 | Estradiol | Estradiol results in decreased expression of CDKN1B mRNA | 22064387 |
| D004958 | Estradiol | Estradiol results in increased degradation of CDKN1B protein | 17283133 |
| D004958 | Estradiol | Estradiol results in increased phosphorylation of CDKN1B protein | 23029392 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in increased degradation of CDKN1B protein] | 17283133|2302939 |
| D004958 | Estradiol | lactacystin inhibits the reaction [Estradiol results in increased degradation of CDKN1B protein] | 17283133|2302939 |
| D004958 | Estradiol | MAPK1 protein affects the reaction [Estradiol results in increased phosphorylation of CDKN1B protein] | 23029392 |
| D004958 | Estradiol | MAPK3 protein affects the reaction [Estradiol results in increased phosphorylation of CDKN1B protein] | 23029392 |
| D004958 | Estradiol | Mifepristone inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CDKN1B protein] | 17283133 |
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in increased expression of and results in increased stability of CDKN1B protein | 23029392 |
| D004958 | Estradiol | SKP2 mutant form inhibits the reaction [Estradiol results in increased degradation of CDKN1B protein] | 23029392 |
| D004958 | Estradiol | Estradiol affects the expression of CDKN1B mRNA | 15598610 |
| D004958 | Estradiol | Estradiol results in increased expression of CDKN1B mRNA | 17640349 |
| C023888 | beta-hexachlorocyclohexane | beta-hexachlorocyclohexane results in increased expression of CDKN1B mRNA | 17640349 |
| C053541 | bicalutamide | bicalutamide results in increased expression of CDKN1B | 11845989 |
| C519495 | BIM 23120 | [BIM 23120 results in increased activity of SSTR2 protein] which results in increased expression of CDKN1B protein | 16954443 |
| C519496 | BIM 23206 | [BIM 23206 results in increased activity of SSTR5 protein] which results in increased expression of CDKN1B protein | 16954443 |
| C543008 | bis(4-hydroxyphenyl)sulfone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDKN1B mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A affects the expression of CDKN1B mRNA | 21786754 |
| C006780 | bisphenol A | bisphenol A affects the expression of CDKN1B protein | 25130739 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of CDKN1B mRNA | 27998958 |
| C006780 | bisphenol A | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1B mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A results in increased expression of CDKN1B mRNA | 26063408 |
| C006780 | bisphenol A | bisphenol A results in increased expression of CDKN1B protein | 24809654 |
| C006780 | bisphenol A | bisphenol A results in increased expression of CDKN1B protein | 21722727 |
| C006780 | bisphenol A | bisphenol A results in increased expression of CDKN1B mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased expression of CDKN1B protein | 20692330 |
| C006780 | bisphenol A | bisphenol A results in increased expression of CDKN1B mRNA | 28988043 |
| C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDKN1B mRNA | 28628672 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in decreased expression of CDKN1B mRNA | 17553608 |
| C492810 | BL1521 | BL1521 results in decreased expression of CDKN1B protein | 15733867 |
| D000069286 | Bortezomib | [Bortezomib co-treated with Butyrates] results in increased cleavage of CDKN1B protein | 15173093 |
| D000069286 | Bortezomib | [Bortezomib co-treated with vorinostat] results in increased cleavage of CDKN1B protein | 15173093 |
| D000069286 | Bortezomib | Bortezomib promotes the reaction [lapatinib results in increased expression of CDKN1B protein] | 20701607 |
| D000069286 | Bortezomib | Bortezomib results in increased expression of CDKN1B protein | 14749476|1517309 |
| D000069286 | Bortezomib | Bortezomib results in increased stability of CDKN1B protein | 15543232 |
| D000069286 | Bortezomib | Cisplatin promotes the reaction [Bortezomib results in increased expression of CDKN1B protein] | 19636294 |
| D000069286 | Bortezomib | lapatinib promotes the reaction [Bortezomib results in increased expression of CDKN1B protein] | 20701607 |
| D000069286 | Bortezomib | [vorinostat co-treated with Bortezomib] results in increased expression of CDKN1B protein | 19220424 |
| D000069286 | Bortezomib | Bortezomib affects the localization of CDKN1B protein | 17148762 |
| D000069286 | Bortezomib | Bortezomib results in increased expression of CDKN1B protein | 18451165 |
| C471992 | bosutinib | bosutinib results in increased expression of CDKN1B protein | 17129604 |
| C471992 | bosutinib | Imatinib Mesylate promotes the reaction [bosutinib results in increased expression of CDKN1B protein] | 17129604 |
| C023623 | brassinolide | brassinolide results in decreased expression of CDKN1B protein | 20833159 |
| C013418 | bromfenacoum | bromfenacoum results in decreased expression of CDKN1B protein | 28903499 |
| D019819 | Budesonide | Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1B protein] | 12117777 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of CDKN1B protein] | 17602960 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of CDKN1B protein] | 17602960 |
| C026105 | butylidenephthalide | butylidenephthalide results in increased expression of CDKN1B protein | 16987298 |
| D002087 | Butyrates | [Bortezomib co-treated with Butyrates] results in increased cleavage of CDKN1B protein | 15173093 |
| D002087 | Butyrates | Butyrates results in increased expression of CDKN1B mRNA | 16112107|1743112 |
| D002087 | Butyrates | Butyrates results in increased expression of CDKN1B protein | 17431121 |
| D002087 | Butyrates | PPARG protein affects the reaction [Butyrates results in increased expression of CDKN1B mRNA] | 16112107 |
| D002087 | Butyrates | Tretinoin promotes the reaction [Butyrates results in increased expression of CDKN1B mRNA] | 17431121 |
| D002087 | Butyrates | Tretinoin promotes the reaction [Butyrates results in increased expression of CDKN1B protein] | 17431121 |
| D002104 | Cadmium | Cadmium results in decreased expression of CDKN1B protein | 27658547 |
| D002104 | Cadmium | Cadmium results in increased expression of CDKN1B protein | 16730872 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of CDKN1B protein | 27510461 |
| D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDKN1B protein] | 11516527|1213562 |
| D019256 | Cadmium Chloride | Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA] | 12135628 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of CDKN1B mRNA | 18636176 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CDKN1B protein | 16730872 |
| C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester results in increased expression of CDKN1B protein | 15885897 |
| D002122 | Calcium Chloride | Calcium Chloride inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] | 12189186 |
| C071482 | calpeptin | calpeptin results in decreased expression of CDKN1B protein modified form | 22432027 |
| D002211 | Capsaicin | Capsaicin results in decreased expression of CDKN1B protein | 22226932 |
| D002211 | Capsaicin | Capsaicin results in increased expression of CDKN1B protein | 19855437 |
| D002211 | Capsaicin | Capsaicin results in increased expression of CDKN1B | 20069556 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of CDKN1B mRNA | 24752500 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of CDKN1B protein | 12759355 |
| D002251 | Carbon Tetrachloride | CDKN1B protein affects the reaction [Carbon Tetrachloride results in increased expression of CDKN1A protein] | 12759355 |
| D002259 | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone promotes the reaction [CDKN1B protein binds to CDK4 protein] | 19819288 |
| D002259 | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in increased expression of CDKN1B protein | 19819288 |
| C010063 | carbonyl sulfide | carbonyl sulfide results in increased expression of CDKN1B mRNA | 19395590 |
| C054133 | casticin | casticin results in increased expression of CDKN1B mRNA | 27862857 |
| C103436 | CB 1093 | CB 1093 promotes the reaction [CDKN1B protein binds to CDK2 protein] | 12907249 |
| C103436 | CB 1093 | CB 1093 results in increased expression of and results in decreased degradation of CDKN1B protein | 12907249 |
| C103436 | CB 1093 | CB 1093 results in increased expression of CDKN1B mRNA | 12907249 |
| D000068579 | Celecoxib | [Atorvastatin Calcium co-treated with Celecoxib] results in increased expression of CDKN1B protein | 18172863 |
| D000068579 | Celecoxib | Celecoxib promotes the reaction [Valproic Acid results in increased expression of CDKN1B protein] | 21737646 |
| D000068579 | Celecoxib | Celecoxib results in increased expression of CDKN1B mRNA | 19428934 |
| D000068579 | Celecoxib | Celecoxib results in increased expression of CDKN1B protein | 19428934|2173764 |
| D000068579 | Celecoxib | Valproic Acid promotes the reaction [Celecoxib results in increased expression of CDKN1B protein] | 21737646 |
| D000068579 | Celecoxib | Celecoxib results in increased activity of CDKN1B | 19706164 |
| C532683 | Cellfood | Cellfood results in increased expression of CDKN1B protein | 24598211 |
| D002509 | Cephaloridine | Cephaloridine results in decreased expression of CDKN1B mRNA | 18500788 |
| D002635 | Chenodeoxycholic Acid | Chenodeoxycholic Acid affects the localization of CDKN1B protein | 20818264 |
| C100187 | chloropicrin | chloropicrin results in increased expression of CDKN1B protein | 24548678 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of CDKN1B mRNA | 21356183 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDKN1B gene | 20938992 |
| C074702 | chromium hexavalent ion | AKT1 protein affects the reaction [Vanadates inhibits the reaction [chromium hexavalent ion affects the localization of CDKN1B protein]] | 19377290 |
| C074702 | chromium hexavalent ion | AKT1 protein modified form inhibits the reaction [chromium hexavalent ion affects the localization of CDKN1B protein] | 19377290 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion results in decreased expression of and affects the localization of CDKN1B protein | 19377290 |
| C074702 | chromium hexavalent ion | Vanadates inhibits the reaction [chromium hexavalent ion results in decreased expression of and affects the localization of CDKN1B protein] | 19377290 |
| C074702 | chromium hexavalent ion | [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of CDKN1B mRNA | 25820237 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion results in increased expression of CDKN1B protein | 21621607 |
| C039671 | ciglitazone | ciglitazone results in increased expression of CDKN1B mRNA | 20578043 |
| C086108 | clobenpropit | [HRH4 protein results in increased susceptibility to clobenpropit] which results in increased expression of CDKN1B protein | 22363581 |
| D002995 | Clofibric Acid | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDKN1B mRNA | 17602206 |
| D003022 | Clotrimazole | Clotrimazole results in increased expression of CDKN1B | 20724915 |
| D009243 | NAD | NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein] | 22561310 |
| D009243 | NAD | SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] | 22561310 |
| D003300 | Copper | [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein | 24690739 |
| D003300 | Copper | [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein | 24690739 |
| D003345 | Corticosterone | Corticosterone promotes the reaction [CDKN1B protein binds to CDK4 protein] | 12807724 |
| D003345 | Corticosterone | Corticosterone results in increased expression of CDKN1B protein | 12807724 |
| C477330 | CP-654577 | CP-654577 results in increased expression of CDKN1B protein | 12907618 |
| C542041 | cudraflavone B | cudraflavone B results in increased expression of CDKN1B protein | 23881456 |
| C542041 | cudraflavone B | resveratrol inhibits the reaction [cudraflavone B results in increased expression of CDKN1B protein] | 23881456 |
| C542041 | cudraflavone B | sirtinol promotes the reaction [cudraflavone B results in increased expression of CDKN1B protein] | 23881456 |
| C029892 | cupric chloride | cupric chloride affects the expression of CDKN1B protein | 23313662 |
| C030973 | cupric oxide | cupric oxide results in decreased expression of CDKN1B mRNA | 22077320 |
| D003474 | Curcumin | AR protein affects the reaction [[Curcumin co-treated with Quercetin] results in increased expression of CDKN1B protein] | 27132804 |
| D003474 | Curcumin | [arsenic trioxide co-treated with Curcumin] results in increased expression of CDKN1B protein | 27430728 |
| D003474 | Curcumin | [Curcumin co-treated with Quercetin] results in increased expression of CDKN1B protein | 27132804 |
| D003474 | Curcumin | Curcumin results in decreased expression of CDKN1B protein | 18593936 |
| D003474 | Curcumin | Curcumin results in increased expression of CDKN1B mRNA | 15713895 |
| D003474 | Curcumin | Curcumin results in increased expression of CDKN1B protein | 18156803|1822626 |
| D003474 | Curcumin | Dihydrotestosterone inhibits the reaction [[Curcumin co-treated with Quercetin] results in increased expression of CDKN1B protein] | 27132804 |
| D003474 | Curcumin | TNFSF10 protein promotes the reaction [Curcumin results in increased expression of CDKN1B protein] | 18226269 |
| D003474 | Curcumin | Curcumin results in increased expression of CDKN1B mRNA | 25822711 |
| D003474 | Curcumin | Curcumin results in increased expression of CDKN1B protein | 21594647 |
| D003474 | Curcumin | Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of CDKN1B protein] | 17602960 |
| D003474 | Curcumin | Curcumin results in increased expression of CDKN1B protein | 17602960 |
| C038459 | curdlan | curdlan results in decreased expression of CDKN1B mRNA | 23543010 |
| C009160 | cyclonite | cyclonite results in decreased expression of CDKN1B mRNA | 19417177 |
| C013905 | cyclopentenone | cyclopentenone results in increased expression of CDKN1B | 16061222 |
| D003520 | Cyclophosphamide | [Doxorubicin co-treated with Cyclophosphamide] affects the expression of CDKN1B mRNA | 16322899 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of CDKN1B mRNA | 25562108 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of CDKN1B mRNA | 20106945 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of CDKN1B mRNA | 21865292 |
| C072247 | cyclo(Trp-Asp-Pro-Val-Leu) | cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [VEGFC protein results in decreased expression of CDKN1B protein] | 24184161 |
| D003545 | Cysteine | Cysteine analog results in decreased expression of CDKN1B protein | 15890017 |
| D003571 | Cytochalasin B | Cytochalasin B results in increased expression of CDKN1B protein | 27640744 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Mimosine results in increased expression of CDKN1B mRNA] | 10623466 |
| C109268 | darbufelone | darbufelone results in increased expression of CDKN1B mRNA | 20352217 |
| C109268 | darbufelone | darbufelone results in increased expression of CDKN1B protein | 20352217 |
| D000069439 | Dasatinib | Dasatinib results in increased expression of CDKN1B protein | 16740687|2014516 |
| D003630 | Daunorubicin | Daunorubicin affects the expression of CDKN1B mRNA | 20037814 |
| D003630 | Daunorubicin | fasudil affects the reaction [Daunorubicin affects the expression of CDKN1B mRNA] | 20037814 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in decreased expression of CDKN1B protein | 28572024 |
| C014347 | decitabine | [decitabine affects the expression of DNMT3B protein] which affects the expression of CDKN1B mRNA | 18544619 |
| C014347 | decitabine | [decitabine co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Sirolimus] results in increased expression of CDKN1B mRNA | 18622747 |
| C014347 | decitabine | [decitabine co-treated with trichostatin A] results in increased expression of CDKN1B mRNA | 17185465 |
| C014347 | decitabine | decitabine results in decreased expression of CDKN1B mRNA | 27915011 |
| D013759 | Dronabinol | Dronabinol results in increased expression of CDKN1B mRNA | 18454173 |
| D013759 | Dronabinol | JUND mutant form inhibits the reaction [Dronabinol results in increased expression of CDKN1B mRNA] | 18454173 |
| D013759 | Dronabinol | TES mutant form inhibits the reaction [Dronabinol results in increased expression of CDKN1B mRNA] | 18454173 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of CDKN1B mRNA | 19428934 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of CDKN1B protein | 19428934 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDKN1B mRNA | 28628672 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1B mRNA | 28628672 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDKN1B mRNA | 28628672 |
| D003907 | Dexamethasone | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein | 25559859 |
| D003907 | Dexamethasone | "5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in decreased expression of CDKN1B protein]" | 24646949 |
| D003907 | Dexamethasone | [INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in decreased expression of CDKN1B protein | 24646949 |
| D003907 | Dexamethasone | silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein] | 25559859 |
| C004717 | diacetylmonoxime | diacetylmonoxime results in increased expression of CDKN1B protein | 15252113 |
| C042577 | diallyl trisulfide | diallyl trisulfide results in increased expression of CDKN1B protein | 14693049 |
| C023614 | dibenzofuran | AHR protein promotes the reaction [dibenzofuran analog results in increased expression of CDKN1B mRNA] | 20566336 |
| C023614 | dibenzofuran | dibenzofuran analog results in increased expression of CDKN1B mRNA | 20566336 |
| C023614 | dibenzofuran | dibenzofuran analog results in increased expression of CDKN1B protein | 20566336 |
| D003994 | Bucladesine | Bucladesine results in increased expression of CDKN1B protein | 16718685|2169343 |
| D002945 | Cisplatin | CDKN1B results in decreased susceptibility to Cisplatin | 21652059 |
| D002945 | Cisplatin | [Cisplatin co-treated with Quercetin] results in increased expression of CDKN1B mRNA | 27514524 |
| D002945 | Cisplatin | [Cisplatin inhibits the reaction [[Sirolimus results in increased phosphorylation of AKT1 protein] which results in increased phosphorylation of FOXO3 protein]] which results in increased expression of CDKN1B protein | 21092744 |
| D002945 | Cisplatin | Cisplatin promotes the reaction [Bortezomib results in increased expression of CDKN1B protein] | 19636294 |
| D002945 | Cisplatin | Cisplatin promotes the reaction [MIR630 mRNA results in increased expression of CDKN1B protein] | 20145152 |
| D002945 | Cisplatin | Cisplatin results in increased expression of CDKN1B mRNA | 21092744 |
| D002945 | Cisplatin | Cisplatin results in increased expression of CDKN1B protein | 21274007 |
| D002945 | Cisplatin | Sirolimus promotes the reaction [Cisplatin results in increased expression of CDKN1B mRNA] | 21092744 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of CDKN1B mRNA | 21151649 |
| D004008 | Diclofenac | Diclofenac affects the expression of CDKN1B mRNA | 24752500 |
| D019259 | Lamivudine | [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1B mRNA | 15784690 |
| C020283 | diethanolamine | diethanolamine results in decreased expression of CDKN1B mRNA | 16014740 |
| C020283 | diethanolamine | diethanolamine results in decreased expression of CDKN1B mRNA | 16014740 |
| D004052 | Diethylnitrosamine | CDKN1B protein inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDK2 protein] | 17620307 |
| D004052 | Diethylnitrosamine | CDKN1B results in decreased susceptibility to [Diethylnitrosamine co-treated with Phenobarbital] | 17620307 |
| D004052 | Diethylnitrosamine | 2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein] | 17582756 |
| D004052 | Diethylnitrosamine | [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA | 18544905 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDKN1B mRNA | 17602206 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA | 18544905 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of CDKN1B protein | 17582756 |
| D004052 | Diethylnitrosamine | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA | 18253720 |
| D004052 | Diethylnitrosamine | pioglitazone inhibits the reaction [2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]] | 17582756 |
| D004052 | Diethylnitrosamine | pioglitazone promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein] | 17582756 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of CDKN1B protein | 21722727 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in decreased expression of CDKN1B mRNA | 21658437 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of CDKN1B mRNA | 17292805 |
| D004074 | Digitoxin | Digitoxin analog results in decreased expression of CDKN1B protein | 22037315 |
| D004074 | Digitoxin | Digitoxin results in decreased expression of CDKN1B protein | 22037315 |
| D002117 | Calcitriol | Calcitriol promotes the reaction [CDKN1B protein binds to CDK4 protein] | 16322758 |
| D002117 | Calcitriol | Calcitriol results in decreased phosphorylation of and results in decreased degradation of and results in increased stability of CDKN1B protein | 12954644 |
| D002117 | Calcitriol | Calcitriol results in increased expression of CDKN1B | 11519864 |
| D002117 | Calcitriol | Calcitriol results in increased expression of CDKN1B mRNA | 11270487|9783903 |
| D002117 | Calcitriol | Calcitriol results in increased expression of CDKN1B protein | 10825140|1603911 |
| D004125 | Dimethyldithiocarbamate | [Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein | 17079469 |
| D004221 | Disulfiram | Disulfiram results in decreased expression of CDKN1B mRNA | 20530235 |
| D004221 | Disulfiram | [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein | 24690739 |
| D004221 | Disulfiram | Disulfiram results in increased expression of CDKN1B protein | 17079463 |
| D004221 | Disulfiram | [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein | 24690739 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in increased expression of CDKN1B protein | 19272428 |
| D004317 | Doxorubicin | CDKN1B results in decreased susceptibility to Doxorubicin | 21652059 |
| D004317 | Doxorubicin | Doxorubicin affects the expression of CDKN1B mRNA | 16705698 |
| D004317 | Doxorubicin | Doxorubicin affects the expression of CDKN1B protein | 16036217|1789351 |
| D004317 | Doxorubicin | [Doxorubicin co-treated with Cyclophosphamide] affects the expression of CDKN1B mRNA | 16322899 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of CDKN1B protein | 17935137 |
| D004317 | Doxorubicin | wortmannin promotes the reaction [Doxorubicin results in increased expression of CDKN1B protein] | 17935137 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of CDKN1B protein" | 23239598|2331583 |
| C034192 | ellipticine | ellipticine results in decreased expression of CDKN1B protein | 21843585 |
| C070609 | EMD 53998 | EMD 53998 analog results in increased expression of CDKN1B mRNA | 24977338 |
| C118739 | entinostat | [fludarabine co-treated with entinostat] results in decreased expression of CDKN1B protein | 15059916 |
| C551471 | EPI 001 | EPI 001 results in increased expression of CDKN1B protein | 25669987 |
| C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDKN1B mRNA | 22079256 |
| C498475 | equiguard | equiguard results in decreased expression of CDKN1B protein | 15547720 |
| C498475 | equiguard | equiguard results in increased expression of CDKN1B protein | 15547720 |
| C472787 | erucylphospho-N,N,N-trimethylpropylammonium | "erucylphospho-N,N,N-trimethylpropylammonium results in increased expression of CDKN1B" | 24987858 |
| C472787 | erucylphospho-N,N,N-trimethylpropylammonium | "RB1 mutant form inhibits the reaction [erucylphospho-N,N,N-trimethylpropylammonium results in increased expression of CDKN1B]" | 24987858 |
| D004967 | Estrogens | [Estrogens co-treated with INS protein] inhibits the reaction [PTEN protein results in increased expression of CDKN1B protein] | 11230179 |
| D004967 | Estrogens | Estrogens inhibits the reaction [PTEN protein results in increased expression of CDKN1B protein] | 11230179 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CDKN1B mRNA | 16872691 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of CDKN1B mRNA | 17557909 |
| C002994 | ethylene dimethanesulfonate | ethylene dimethanesulfonate results in decreased expression of CDKN1B mRNA | 22711419 |
| D005047 | Etoposide | Etoposide results in increased expression of CDKN1B protein | 17935137 |
| D005047 | Etoposide | wortmannin promotes the reaction [Etoposide results in increased expression of CDKN1B protein] | 17935137 |
| D005054 | Eugenol | Eugenol results in increased expression of CDKN1B protein | 22686307 |
| C049347 | fasudil | fasudil affects the reaction [Daunorubicin affects the expression of CDKN1B mRNA] | 20037814 |
| D011345 | Fenofibrate | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA | 18253720 |
| C017690 | fenvalerate | CDKN1B protein inhibits the reaction [fenvalerate results in increased expression of CDK2 mRNA] | 22850687 |
| C017690 | fenvalerate | CDKN1B protein results in decreased susceptibility to fenvalerate | 22850687 |
| C017690 | fenvalerate | fenvalerate results in decreased expression of CDKN1B mRNA | 22850687 |
| C017690 | fenvalerate | fenvalerate results in decreased expression of CDKN1B protein | 22850687 |
| C000499 | ferric oxide | [ferric oxide analog co-treated with Acrolein] results in decreased expression of CDKN1B protein | 24847785 |
| D005411 | Flame Retardants | Flame Retardants results in increased expression of CDKN1B protein | 18952254 |
| C028610 | flavanone | flavanone results in increased expression of CDKN1B protein | 22056764 |
| C544127 | flavomannin-6,6'-dimethylether | "flavomannin-6,6'-dimethylether results in increased expression of CDKN1B protein" | 19686795 |
| C024352 | fludarabine | [fludarabine co-treated with entinostat] results in decreased expression of CDKN1B protein | 15059916 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein] | 17582756 |
| D015073 | 2-Acetylaminofluorene | pioglitazone inhibits the reaction [2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]] | 17582756 |
| D005472 | Fluorouracil | CDKN1B protein affects the susceptibility to Fluorouracil | 17217824 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of CDKN1B mRNA | 18930000 |
| D005473 | Fluoxetine | Fluoxetine affects the expression of CDKN1B mRNA | 18371935 |
| D005473 | Fluoxetine | [Fluoxetine results in decreased activity of CKS1B protein] which results in decreased degradation of CDKN1B protein | 18371935 |
| D005473 | Fluoxetine | Fluoxetine results in increased expression of CDKN1B mRNA | 21497159 |
| D005485 | Flutamide | Flutamide results in decreased expression of CDKN1B mRNA | 24136188 |
| D005492 | Folic Acid | Folic Acid affects the expression of CDKN1B mRNA | 16361273 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDKN1B gene | 20938992 |
| C096856 | FTI 277 | [Tamoxifen co-treated with FTI 277] promotes the reaction [CDKN1B protein binds to [CCNE1 protein binds to CDK2 protein]] | 12866041 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in increased degradation of CDKN1B protein] | 17283133|2302939 |
| C070081 | fulvestrant | fulvestrant results in increased expression of CDKN1B protein | 21367843 |
| D062610 | Fungal Polysaccharides | Fungal Polysaccharides results in increased expression of CDKN1B mRNA | 24060681 |
| D062610 | Fungal Polysaccharides | Fungal Polysaccharides results in increased expression of CDKN1B protein | 24060681 |
| C039281 | furan | furan results in increased expression of CDKN1B mRNA | 22079235 |
| D005707 | Gallic Acid | Gallic Acid results in increased expression of CDKN1B protein | 22245431 |
| D024504 | gamma-Tocopherol | gamma-Tocopherol results in decreased expression of CDKN1B protein | 12368234 |
| C419708 | gefitinib | gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein] | 16322342 |
| C419708 | gefitinib | gefitinib results in decreased expression of CDKN1B | 14679152 |
| C419708 | gefitinib | gefitinib results in increased expression of CDKN1B protein | 16740687|1751360 |
| C056507 | gemcitabine | CDKN1B results in decreased susceptibility to gemcitabine | 21652059 |
| D019833 | Genistein | Genistein results in increased expression of CDKN1B protein | 15829497 |
| D019833 | Genistein | Genistein results in increased expression of CDKN1B mRNA | 21048042 |
| D019833 | Genistein | Genistein results in increased expression of CDKN1B mRNA | 28988043 |
| C007845 | gingerol | gingerol results in decreased expression of CDKN1B mRNA | 28249781 |
| D005897 | Glafenine | Glafenine results in decreased expression of CDKN1B mRNA | 24136188 |
| D005938 | Glucocorticoids | Glucocorticoids results in increased expression of CDKN1B protein | 15034294 |
| D005944 | Glucosamine | Glucosamine results in decreased expression of CDKN1B protein | 15654767 |
| D005947 | Glucose | Glucose results in increased expression of CDKN1B protein | 22561310 |
| D005947 | Glucose | NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein] | 22561310 |
| D005947 | Glucose | Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] | 22561310 |
| D005947 | Glucose | resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein] | 22561310 |
| D005947 | Glucose | Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein] | 22561310 |
| D005947 | Glucose | SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] | 22561310 |
| D005947 | Glucose | SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] | 22561310 |
| D005947 | Glucose | SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] | 22561310 |
| D005678 | G(M2) Ganglioside | G(M2) Ganglioside results in decreased expression of CDKN1B protein | 15654767 |
| D006046 | Gold | [Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein | 17079469 |
| C568713 | GSK1210151A | GSK1210151A results in increased expression of CDKN1B protein | 26254443 |
| D006247 | Harmine | Harmine results in decreased phosphorylation of CDKN1B protein | 26953159 |
| D006427 | Hemin | Hemin results in decreased degradation of CDKN1B protein | 17283133 |
| D006493 | Heparin | Heparin analog results in decreased expression of CDKN1B protein | 20201787 |
| D006493 | Heparin | Heparin analog results in increased expression of CDKN1B protein | 18057711 |
| C013015 | hesperetin | hesperetin results in increased expression of CDKN1B | 17927510 |
| C089796 | hexabromocyclododecane | hexabromocyclododecane results in decreased expression of CDKN1B mRNA | 26804032 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene affects the reaction [CDKN1B protein binds to SRC protein] | 28215542 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene promotes the reaction [CDKN1B protein binds to CCNE1 protein] | 28215542 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased expression of CDKN1B protein | 25093615 |
| C014026 | hexamethylene bisacetamide | hexamethylene bisacetamide results in increased expression of CDKN1B mRNA | 17349212 |
| D006632 | Histamine | [HRH4 protein results in increased susceptibility to Histamine] which results in increased expression of CDKN1B protein | 22363581 |
| C070164 | homocastasterone | homocastasterone results in increased expression of CDKN1B protein | 20833159 |
| D017313 | Fenretinide | Fenretinide results in increased expression of CDKN1B protein | 16270382 |
| D006830 | Hydralazine | [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein | 11318962 |
| D006835 | Hydrazones | Hydrazones results in increased expression of CDKN1B protein | 22056764 |
| D006851 | Hydrochloric Acid | Hydrochloric Acid affects the localization of CDKN1B protein | 20818264 |
| D006852 | Hydrochlorothiazide | [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein | 11318962 |
| D006918 | Hydroxyurea | Hydroxyurea results in increased expression of CDKN1B protein | 10961388 |
| D006918 | Hydroxyurea | [Valproic Acid co-treated with Hydroxyurea] results in increased expression of CDKN1B mRNA | 17653085 |
| C559745 | hyperforin dicyclohexylammonium | hyperforin dicyclohexylammonium results in increased expression of CDKN1B protein | 21376709 |
| C492448 | ICG 001 | ICG 001 results in decreased expression of CDKN1B mRNA | 26191083 |
| D000068877 | Imatinib Mesylate | [vorinostat co-treated with Imatinib Mesylate] results in increased expression of CDKN1B protein | 12446442 |
| D000068877 | Imatinib Mesylate | Imatinib Mesylate promotes the reaction [bosutinib results in increased expression of CDKN1B protein] | 17129604 |
| D000068877 | Imatinib Mesylate | Imatinib Mesylate promotes the reaction [wortmannin results in increased expression of CDKN1B protein] | 17129604 |
| C027185 | indirubin | indirubin promotes the reaction [tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein]] | 18344322 |
| C027185 | indirubin | indirubin promotes the reaction [tanshinone results in increased expression of CDKN1B protein] | 18344322 |
| C027185 | indirubin | indirubin promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein] | 18344322 |
| C027185 | indirubin | indirubin results in increased expression of CDKN1B protein | 18344322 |
| C027185 | indirubin | tanshinone promotes the reaction [indirubin promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein]] | 18344322 |
| C027185 | indirubin | tetraarsenic tetrasulfide promotes the reaction [indirubin promotes the reaction [tanshinone results in increased expression of CDKN1B protein]] | 18344322 |
| C016517 | indole-3-carbinol | indole-3-carbinol analog results in increased expression of CDKN1B protein | 20570586 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased expression of CDKN1B | 16082211 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of CDKN1B mRNA | 16984733 |
| D007213 | Indomethacin | Indomethacin results in increased expression of CDKN1B mRNA | 19428934 |
| D007213 | Indomethacin | Indomethacin results in increased expression of CDKN1B protein | 11260862|1942893 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDKN1B mRNA | 28628672 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1B mRNA | 28628672 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDKN1B mRNA | 28628672 |
| C409043 | inecalcitol | inecalcitol results in increased expression of CDKN1B protein | 10825140 |
| C572449 | INK128 | INK128 results in increased expression of CDKN1B protein | 26536665 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CDKN1B mRNA | 25613284 |
| C506002 | ircinin-1 | ircinin-1 results in increased expression of CDKN1B mRNA | 16163705 |
| C506002 | ircinin-1 | ircinin-1 results in increased expression of CDKN1B protein | 16163705 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDKN1B mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1B mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDKN1B mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein | 25559859 |
| D015056 | 1-Methyl-3-isobutylxanthine | "5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in decreased expression of CDKN1B protein]" | 24646949 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in decreased expression of CDKN1B protein | 24646949 |
| D015056 | 1-Methyl-3-isobutylxanthine | silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein] | 25559859 |
| C036643 | isoeugenol | isoeugenol results in increased expression of CDKN1B protein | 22686307 |
| D007529 | Isoflavones | Isoflavones results in increased expression of CDKN1B protein | 17374662 |
| C040920 | isoliquiritigenin | isoliquiritigenin results in decreased expression of CDKN1B mRNA | 27702603 |
| C550177 | isoliquiritigenin 2'-methyl ether | isoliquiritigenin 2'-methyl ether results in decreased expression of CDKN1B protein | 20040371 |
| C561695 | (+)-JQ1 compound | [(+)-JQ1 compound co-treated with vemurafenib] results in increased expression of CDKN1B protein | 27169980 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of CDKN1B mRNA | 26830473 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in increased expression of CDKN1B | 26575167|2725637 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in increased expression of CDKN1B mRNA | 24796395|2527752 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in increased expression of CDKN1B protein | 23792448|2443544 |
| D007654 | Ketoconazole | Ketoconazole results in increased expression of CDKN1B mRNA | 25808816 |
| C074279 | KH 1060 | KH 1060 promotes the reaction [CDKN1B protein binds to CDK2 protein] | 12907249 |
| C074279 | KH 1060 | KH 1060 results in increased expression of and results in decreased degradation of CDKN1B protein | 12907249 |
| C074279 | KH 1060 | KH 1060 results in increased expression of CDKN1B mRNA | 12907249 |
| C011890 | kojic acid | [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA | 18544905 |
| C011890 | kojic acid | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA | 18544905 |
| C500368 | labedipinedilol A | labedipinedilol A results in increased expression of CDKN1B protein | 19056458 |
| C067713 | lactacystin | lactacystin inhibits the reaction [Estradiol results in increased degradation of CDKN1B protein] | 17283133|2302939 |
| C067713 | lactacystin | lactacystin results in increased expression of CDKN1B protein | 12149143 |
| C490728 | lapatinib | [afimoxifene co-treated with lapatinib] promotes the reaction [CDKN1B protein binds to and results in decreased activity of [CCNE1 protein binds to CDK2 protein]] | 15665275 |
| C490728 | lapatinib | [afimoxifene co-treated with lapatinib] results in increased expression of CDKN1B protein | 15665275 |
| C490728 | lapatinib | Bortezomib promotes the reaction [lapatinib results in increased expression of CDKN1B protein] | 20701607 |
| C490728 | lapatinib | lapatinib promotes the reaction [Bortezomib results in increased expression of CDKN1B protein] | 20701607 |
| C490728 | lapatinib | lapatinib promotes the reaction [CDKN1B protein binds to and results in decreased activity of [CCNE1 protein binds to CDK2 protein]] | 15665275 |
| C490728 | lapatinib | lapatinib results in increased expression of CDKN1B protein | 15665275|2070160 |
| D008012 | Lidocaine | Lidocaine affects the expression of CDKN1B mRNA | 18931217 |
| C018584 | linalool | linalool results in increased expression of CDKN1B mRNA | 19922762 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides affects the expression of CDKN1B protein | 12883080 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CDKN1B mRNA | 12883080 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CDKN1B protein alternative form | 12883080 |
| D008070 | Lipopolysaccharides | Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides affects the expression of CDKN1B protein] | 12883080 |
| D008070 | Lipopolysaccharides | Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of CDKN1B mRNA] | 12883080 |
| D008070 | Lipopolysaccharides | Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of CDKN1B protein alternative form] | 12883080 |
| D008094 | Lithium | Lithium results in decreased expression of CDKN1B mRNA | 15687245 |
| D008094 | Lithium | Lithium results in decreased expression of CDKN1B protein | 15687245|1829663 |
| D018021 | Lithium Chloride | Lithium Chloride results in decreased expression of CDKN1B mRNA | 17440966 |
| D008148 | Lovastatin | Lovastatin results in increased expression of CDKN1B protein | 10502407|1511840 |
| D008148 | Lovastatin | Lovastatin results in increased expression of CDKN1B mRNA | 20578043 |
| D008148 | Lovastatin | Lovastatin results in increased expression of CDKN1B protein | 20578043|9848777 |
| D047311 | Luteolin | Luteolin results in increased expression of CDKN1B protein | 11322924 |
| C094099 | LY 293111 | LY 293111 results in increased expression of CDKN1B protein | 16151469 |
| C051883 | maxacalcitol | maxacalcitol results in increased expression of CDKN1B protein | 16039115 |
| D017258 | Medroxyprogesterone Acetate | Estradiol promotes the reaction [Medroxyprogesterone Acetate results in increased expression of CDKN1B protein] | 17283133 |
| D017258 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate results in increased expression of CDKN1B protein | 17283133 |
| D017258 | Medroxyprogesterone Acetate | Mifepristone inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CDKN1B protein] | 17283133 |
| D008627 | Mercuric Chloride | Mercuric Chloride affects the expression of CDKN1B mRNA | 20353558 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDKN1B gene | 20938992 |
| D008727 | Methotrexate | CDKN1B protein affects the susceptibility to Methotrexate | 17217824 |
| D008727 | Methotrexate | Methotrexate results in increased expression of CDKN1B mRNA | 22183962 |
| D008730 | Methoxsalen | Methoxsalen inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] | 15157999 |
| C005219 | methyl cellosolve | methyl cellosolve results in increased expression of CDKN1B mRNA | 19643169 |
| D008748 | Methylcholanthrene | Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein] | 18022818 |
| D008748 | Methylcholanthrene | CDKN1B protein results in increased susceptibility to Methylcholanthrene | 18022818 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CDKN1B protein | 18022818 |
| D008748 | Methylcholanthrene | resveratrol inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein] | 18022818 |
| D008769 | Methylnitronitrosoguanidine | Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDKN1B protein] | 11516527|1213562 |
| D008769 | Methylnitronitrosoguanidine | Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA] | 12135628 |
| D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA | 12135628 |
| D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine results in increased expression of CDKN1B protein | 11516527|1213562 |
| C008493 | methylselenic acid | KLF4 protein affects the reaction [methylselenic acid results in increased expression of CDKN1B mRNA] | 18314491 |
| C008493 | methylselenic acid | methylselenic acid promotes the reaction [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein] | 17847021 |
| C008493 | methylselenic acid | methylselenic acid results in decreased activity of [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein] | 17847021 |
| C008493 | methylselenic acid | methylselenic acid results in increased expression of CDKN1B mRNA | 17847021|1831449 |
| C008493 | methylselenic acid | methylselenic acid results in increased expression of CDKN1B protein | 17847021 |
| C008493 | methylselenic acid | methylselenic acid affects the expression of CDKN1B protein | 12017302 |
| D008777 | Methyltestosterone | Methyltestosterone results in decreased expression of CDKN1B mRNA | 29191790 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CDKN1B protein] | 17283133 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein] | 22266097 |
| D015735 | Mifepristone | Mifepristone promotes the reaction [CDK2 protein binds to CDKN1B protein] | 17545545 |
| D015735 | Mifepristone | Mifepristone promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] | 17545545 |
| D015735 | Mifepristone | Mifepristone results in increased expression of and results in increased localization of CDKN1B protein | 17545545 |
| D008898 | Mimosine | Mimosine results in increased expression of CDKN1B | 10530763 |
| D008898 | Mimosine | Dactinomycin inhibits the reaction [Mimosine results in increased expression of CDKN1B mRNA] | 10623466 |
| D008898 | Mimosine | Mimosine results in increased expression of CDKN1B mRNA | 10623466 |
| D008898 | Mimosine | Mimosine results in increased expression of CDKN1B protein | 10623466 |
| D016685 | Mitomycin | CDKN1B protein affects the susceptibility to Mitomycin | 17217824 |
| C070571 | ML 7 | ML 7 results in increased expression of CDKN1B protein | 15252113 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in decreased expression of CDKN1B mRNA | 20024957 |
| D005677 | G(M1) Ganglioside | G(M1) Ganglioside results in decreased expression of CDKN1B protein | 15654767 |
| C437683 | motexafin gadolinium | motexafin gadolinium results in increased expression of CDKN1B mRNA | 16357179 |
| C437683 | motexafin gadolinium | [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CDKN1B mRNA | 16357179 |
| C523799 | MRK 003 | CDKN1B results in increased susceptibility to MRK 003 | 19318552 |
| C523799 | MRK 003 | MRK 003 results in increased expression of CDKN1B mRNA | 19318552 |
| C523799 | MRK 003 | MRK 003 results in increased expression of CDKN1B protein | 19318552 |
| D009151 | Mustard Gas | Mustard Gas results in decreased expression of CDKN1B mRNA | 15674843 |
| D009173 | Mycophenolic Acid | Mycophenolic Acid inhibits the reaction [IL2 protein results in decreased expression of CDKN1B protein] | 12193749 |
| D009173 | Mycophenolic Acid | Mycophenolic Acid inhibits the reaction [IL2 protein results in decreased expression of CDKN1B protein] | 20736080 |
| C562255 | N-(2-(4-hydroxyphenyl)ethyl)-2-(2,5-dimethoxyphenyl)-3-(3-methoxy-4-hydroxyphenyl)acrylamide | "N-(2-(4-hydroxyphenyl)ethyl)-2-(2,5-dimethoxyphenyl)-3-(3-methoxy-4-hydroxyphenyl)acrylamide results in increased expression of CDKN1B protein" | 21835169 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [VEGFC protein results in decreased expression of CDKN1B protein] | 24184161 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of CDKN1B protein | 14567460 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of CDKN1B mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of CDKN1B mRNA" | 25554681 |
| C031721 | naphthalene | naphthalene results in decreased expression of CDKN1B protein | 18687389 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in decreased expression of CDKN1B mRNA | 20551477 |
| C498045 | NCX 4040 | NCX 4040 results in decreased expression of CDKN1B mRNA | 20188076 |
| C022838 | nickel chloride | HIF1A protein promotes the reaction [nickel chloride results in increased expression of CDKN1B protein] | 28552779 |
| C022838 | nickel chloride | nickel chloride results in increased expression of CDKN1B protein | 28552779 |
| C022838 | nickel chloride | nickel chloride affects the expression of CDKN1B mRNA | 22546817 |
| C017557 | nickel subsulfide | nickel subsulfide results in decreased expression of CDKN1B | 23447020 |
| D009538 | Nicotine | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Nicotine results in decreased expression of CDKN1B protein] | 18805435 |
| D009538 | Nicotine | Nicotine results in decreased expression of CDKN1B protein | 18805435 |
| D009538 | Nicotine | Nicotine results in increased expression of and results in increased stability of CDKN1B protein | 15231866 |
| C021277 | nilutamide | nilutamide results in decreased expression of CDKN1B protein | 16616092 |
| C012655 | nimesulide | nimesulide results in increased expression of CDKN1B | 12717830 |
| C012655 | nimesulide | nimesulide results in increased expression of CDKN1B protein | 14567460 |
| D005996 | Nitroglycerin | Nitroglycerin results in increased expression of CDKN1B mRNA | 12102619 |
| D015112 | 4-Nitroquinoline-1-oxide | 4-Nitroquinoline-1-oxide results in decreased expression of CDKN1B mRNA | 22561872 |
| C090577 | N,N'-bis(salicylideneamino)ethane-manganese(II) | "N,N'-bis(salicylideneamino)ethane-manganese(II) inhibits the reaction [SOD2 gene mutant form results in increased expression of CDKN1B protein]" | 21195081 |
| C466913 | NU2058 | NU2058 results in increased expression of CDKN1B protein | 17599054 |
| C064976 | O(6)-benzylguanine | [temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of CDKN1B protein | 20980775 |
| C064976 | O(6)-benzylguanine | [temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of CDKN1B protein | 20980775 |
| C055122 | orlistat | orlistat results in increased expression of CDKN1B protein | 15138278 |
| C030110 | oxaliplatin | oxaliplatin results in increased expression of CDKN1B protein | 15204521 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in decreased expression of CDKN1B mRNA | 25729387 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of CDKN1B mRNA | 17914565 |
| C570200 | P61-E7 compound | P61-E7 compound results in increased expression of and results in decreased phosphorylation of CDKN1B protein | 22028818 |
| C570200 | P61-E7 compound | RHOA protein affects the reaction [P61-E7 compound results in increased expression of CDKN1B protein] | 22028818 |
| C500026 | palbociclib | palbociclib promotes the reaction [CCND1 protein binds to CDKN1B protein binds to CDK4 protein] | 20473330 |
| C500026 | palbociclib | palbociclib results in decreased expression of CDKN1B protein | 17537993 |
| C500026 | palbociclib | palbociclib results in increased expression of CDKN1B mRNA | 17537993 |
| C500026 | palbociclib | palbociclib results in increased expression of CDKN1B protein | 20473330 |
| C482884 | panduratin A | panduratin A results in increased expression of CDKN1B mRNA | 16497706 |
| C482884 | panduratin A | panduratin A results in increased expression of CDKN1B protein | 16497706 |
| C496932 | panobinostat | panobinostat results in increased expression of CDKN1B protein | 18445700 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of CDKN1B mRNA | 23454527 |
| D010431 | Pentoxifylline | [Pentoxifylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein | 21693435 |
| D010634 | Phenobarbital | CDKN1B protein inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDK2 protein] | 17620307 |
| D010634 | Phenobarbital | CDKN1B results in decreased susceptibility to [Diethylnitrosamine co-treated with Phenobarbital] | 17620307 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of CDKN1B | 15603588 |
| D010713 | Phosphatidylcholines | [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CDKN1B protein | 21695227 |
| D010833 | Phytic Acid | Phytic Acid results in decreased expression of CDKN1B protein | 15868430 |
| D010862 | Pilocarpine | Pilocarpine results in increased expression of CDKN1B mRNA | 17971868 |
| C060836 | pioglitazone | pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased degradation of CDKN1B protein] | 26643070 |
| C060836 | pioglitazone | pioglitazone results in increased expression of CDKN1B protein | 26643070 |
| C060836 | pioglitazone | PRKAA1 protein affects the reaction [pioglitazone results in increased expression of CDKN1B protein] | 26643070 |
| C060836 | pioglitazone | pioglitazone inhibits the reaction [2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]] | 17582756 |
| C060836 | pioglitazone | pioglitazone promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein] | 17582756 |
| D010894 | Piroxicam | Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] | 12189186 |
| D010936 | Plant Extracts | Plant Extracts results in decreased degradation of CDKN1B protein | 24095829 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of CDKN1B mRNA | 23557933 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of CDKN1B protein | 26122529 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls affects the expression of CDKN1B mRNA | 21334430 |
| C060540 | polyhexamethyleneguanidine | polyhexamethyleneguanidine results in increased expression of CDKN1B mRNA | 24583197 |
| C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDKN1B mRNA | 22079256 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of CDKN1B mRNA | 22079256 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of CDKN1B mRNA | 26348139 |
| D011241 | Prednisone | Prednisone results in increased expression of CDKN1B protein | 15034294 |
| C023617 | pregna-4,17-diene-3,16-dione | "pregna-4,17-diene-3,16-dione results in increased expression of CDKN1B protein" | 17475222 |
| D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in increased expression of CDKN1B mRNA | 22064387 |
| D011374 | Progesterone | FZR1 mutant form inhibits the reaction [Progesterone affects the localization of CDKN1B protein] | 23029392 |
| D011374 | Progesterone | Progesterone affects the localization of CDKN1B protein | 23029392 |
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in increased expression of and results in increased stability of CDKN1B protein | 23029392 |
| D011374 | Progesterone | Progesterone promotes the reaction [CDK2 protein binds to CDKN1B protein] | 18850315 |
| D011374 | Progesterone | Progesterone results in increased expression of CDKN1B mRNA | 18850315 |
| D011374 | Progesterone | Progesterone results in increased expression of CDKN1B protein | 18850315 |
| D011374 | Progesterone | TP53 mutant form inhibits the reaction [Progesterone results in increased expression of CDKN1B mRNA] | 18850315 |
| D011374 | Progesterone | TP53 mutant form inhibits the reaction [Progesterone results in increased expression of CDKN1B protein] | 18850315 |
| C107773 | pterostilbene | pterostilbene results in increased expression of CDKN1B protein | 23313376 |
| D011743 | Pyrimidines | Pyrimidines affects the splicing of CDKN1B mRNA | 25281741 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Allylamine results in increased expression of CDKN1B protein] | 15048878 |
| D011794 | Quercetin | AR protein affects the reaction [[Curcumin co-treated with Quercetin] results in increased expression of CDKN1B protein] | 27132804 |
| D011794 | Quercetin | [Cisplatin co-treated with Quercetin] results in increased expression of CDKN1B mRNA | 27514524 |
| D011794 | Quercetin | [Curcumin co-treated with Quercetin] results in increased expression of CDKN1B protein | 27132804 |
| D011794 | Quercetin | Dihydrotestosterone inhibits the reaction [[Curcumin co-treated with Quercetin] results in increased expression of CDKN1B protein] | 27132804 |
| D011794 | Quercetin | Quercetin promotes the reaction [CDKN1B protein binds to CDK2 protein] | 11322924 |
| D011794 | Quercetin | Quercetin results in increased expression of CDKN1B protein | 11322924|1582949 |
| D011799 | Quinazolines | Quinazolines affects the splicing of CDKN1B mRNA | 25281741 |
| D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride results in increased expression of CDKN1B protein | 16536755 |
| D012110 | Reserpine | [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein | 11318962 |
| C059514 | resveratrol | FOXO1 protein affects the reaction [resveratrol results in increased expression of CDKN1B protein] | 21179458 |
| C059514 | resveratrol | FOXO3 protein affects the reaction [resveratrol results in increased expression of CDKN1B protein] | 21179458 |
| C059514 | resveratrol | FOXO4 protein affects the reaction [resveratrol results in increased expression of CDKN1B protein] | 21179458 |
| C059514 | resveratrol | [resveratrol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased expression of CDKN1B protein | 21179458 |
| C059514 | resveratrol | resveratrol inhibits the reaction [cudraflavone B results in increased expression of CDKN1B protein] | 23881456 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein] | 18022818 |
| C059514 | resveratrol | resveratrol promotes the reaction [FOXO3 protein binds to CDKN1B promoter] | 17513867 |
| C059514 | resveratrol | resveratrol results in increased expression of CDKN1B mRNA | 16761963|1808983 |
| C059514 | resveratrol | resveratrol results in increased expression of CDKN1B protein | 15829497|1676196 |
| C059514 | resveratrol | resveratrol results in increased expression of CDKN1B protein | 21980390 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein] | 22561310 |
| C059514 | resveratrol | resveratrol results in decreased expression of CDKN1B mRNA | 25905778 |
| C059514 | resveratrol | SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] | 22561310 |
| C059514 | resveratrol | TNFSF10 protein promotes the reaction [resveratrol results in increased expression of CDKN1B protein] | 21209944 |
| C089032 | rimonabant | rimonabant results in increased expression of CDKN1B protein | 16822929 |
| D019438 | Ritonavir | Ritonavir results in increased expression of CDKN1B mRNA | 19386116 |
| C084904 | Ro 41-5253 | Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein]] | 12421932 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of CDKN1B protein | 20210794 |
| C079905 | rubitecan | [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CDKN1B protein | 21695227 |
| C079905 | rubitecan | rubitecan results in increased expression of CDKN1B protein | 21695227 |
| C018381 | salvin | salvin promotes the reaction [arsenic trioxide results in increased expression of CDKN1B protein] | 23239002 |
| C018381 | salvin | salvin results in increased expression of CDKN1B protein | 23239002 |
| C410958 | sauchinone | sauchinone results in increased expression of CDKN1B protein | 27871897 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein] | 19082730 |
| C002979 | selenomethylselenocysteine | selenomethylselenocysteine results in increased expression of CDKN1B protein | 11396176|1927616 |
| C078903 | seocalcitol | seocalcitol inhibits the reaction [alitretinoin results in increased expression of CDKN1B protein] | 16340750 |
| C078903 | seocalcitol | seocalcitol promotes the reaction [CDKN1B protein binds to CDK2 protein] | 12907249 |
| C078903 | seocalcitol | seocalcitol results in increased expression of and results in decreased degradation of CDKN1B protein | 12907249 |
| C078903 | seocalcitol | seocalcitol results in increased expression of CDKN1B mRNA | 12907249 |
| D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in decreased expression of CDKN1B mRNA" | 16251409 |
| D012715 | Sesame Oil | Sesame Oil results in increased expression of CDKN1B mRNA | 29191790 |
| C516024 | SH-6 compound | SH-6 compound results in increased expression of CDKN1B protein | 17513607 |
| D012834 | Silver | Silver results in decreased expression of CDKN1B mRNA | 27131904 |
| C440975 | silybin | [silybin co-treated with Arsenic] results in increased expression of CDKN1B protein | 25868784 |
| C440975 | silybin | silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein] | 25559859 |
| D019821 | Simvastatin | [Simvastatin results in decreased degradation of CDKN1B protein] which results in decreased activity of CDK2 protein | 17928568 |
| D019821 | Simvastatin | Simvastatin results in increased expression of CDKN1B mRNA | 18337644 |
| D019821 | Simvastatin | Simvastatin results in increased expression of CDKN1B protein | 17428261|2087809 |
| D019821 | Simvastatin | Simvastatin results in increased expression of CDKN1B mRNA | 12963647 |
| D019821 | Simvastatin | Simvastatin results in increased expression of CDKN1B protein | 18804536 |
| D020123 | Sirolimus | [Cisplatin inhibits the reaction [[Sirolimus results in increased phosphorylation of AKT1 protein] which results in increased phosphorylation of FOXO3 protein]] which results in increased expression of CDKN1B protein | 21092744 |
| D020123 | Sirolimus | [decitabine co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Sirolimus] results in increased expression of CDKN1B mRNA | 18622747 |
| D020123 | Sirolimus | [Sirolimus co-treated with TGFB1 protein] affects the localization of CDKN1B protein | 14979923 |
| D020123 | Sirolimus | Sirolimus promotes the reaction [Cisplatin results in increased expression of CDKN1B mRNA] | 21092744 |
| D020123 | Sirolimus | Sirolimus results in decreased degradation of CDKN1B protein | 12565877 |
| D020123 | Sirolimus | Sirolimus results in increased expression of CDKN1B protein | 15070696|1645508 |
| D020123 | Sirolimus | [TGFB1 protein co-treated with Sirolimus] promotes the reaction [CDK2 protein binds to CDKN1B protein] | 12417722 |
| D020123 | Sirolimus | [Sirolimus co-treated with TGFB1 protein] affects the localization of CDKN1B protein | 14979923 |
| D020123 | Sirolimus | [Sirolimus co-treated with TGFB1 protein] promotes the reaction [CDKN1B protein binds to CDK2 protein] | 14979923 |
| D020123 | Sirolimus | [TGFB1 protein co-treated with Sirolimus] promotes the reaction [CDK2 protein binds to CDKN1B protein] | 12417722 |
| D020123 | Sirolimus | Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] | 22561310 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [BTC protein affects the localization of CDKN1B protein] | 19105244 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein] | 22561310 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [IGF1 protein affects the localization of CDKN1B protein] | 19105244 |
| D020123 | Sirolimus | Sirolimus results in decreased expression of CDKN1B protein | 22561310 |
| D020123 | Sirolimus | SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] | 22561310 |
| C439060 | sirtinol | sirtinol promotes the reaction [cudraflavone B results in increased expression of CDKN1B protein] | 23881456 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of CDKN1B mRNA | 16882884 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of CDKN1B mRNA | 14713550 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of CDKN1B protein | 14713550 |
| C017947 | sodium arsenite | SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein] | 19082730 |
| C017947 | sodium arsenite | sodium arsenite affects the expression of CDKN1B mRNA | 24535192 |
| C017947 | sodium arsenite | [sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein | 19082730 |
| C017947 | sodium arsenite | CDKN1B protein affects the reaction [sodium arsenite results in increased activity of CASP3 protein] | 20566634 |
| C017947 | sodium arsenite | CDKN1B protein affects the reaction [sodium arsenite results in increased cleavage of PARP1 protein] | 20566634 |
| C017947 | sodium arsenite | CDKN1B protein affects the reaction [sodium arsenite results in increased phosphorylation of JUN protein] | 20566634 |
| C017947 | sodium arsenite | CDKN1B protein affects the reaction [sodium arsenite results in increased phosphorylation of MAPK8 protein] | 20566634 |
| C017947 | sodium arsenite | CDKN1B protein affects the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein] | 20566634 |
| C017947 | sodium arsenite | CDKN1B protein inhibits the reaction [sodium arsenite results in increased activity of AKT1 protein] | 20566634 |
| C017947 | sodium arsenite | CDKN1B protein inhibits the reaction [sodium arsenite results in increased activity of MAP2K4 protein] | 20566634 |
| C017947 | sodium arsenite | CDKN1B protein inhibits the reaction [sodium arsenite results in increased expression of HSPA1A mRNA] | 20566634 |
| C017947 | sodium arsenite | CDKN1B protein inhibits the reaction [sodium arsenite results in increased expression of HSPA1A protein] | 20566634 |
| C017947 | sodium arsenite | CDKN1B protein inhibits the reaction [sodium arsenite results in increased expression of HSPB1 mRNA] | 20566634 |
| C017947 | sodium arsenite | CDKN1B protein inhibits the reaction [sodium arsenite results in increased expression of HSPB1 protein] | 20566634 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of CDKN1B protein | 10764629 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased expression of CDKN1B protein | 19276161 |
| C471405 | sorafenib | "2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [sorafenib results in increased expression of CDKN1B protein]" | 23036488 |
| C471405 | sorafenib | "sorafenib promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased expression of CDKN1B protein]" | 23036488 |
| C471405 | sorafenib | sorafenib results in increased expression of CDKN1B protein | 19878585|2303648 |
| C471405 | sorafenib | sorafenib results in increased expression of CDKN1B protein | 19139124 |
| C471405 | sorafenib | sorafenib inhibits the reaction [[Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein] | 21693435 |
| C471405 | sorafenib | sorafenib results in decreased expression of CDKN1B protein | 21693435 |
| C530804 | S,S'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea | "S,S'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea results in increased expression of CDKN1B protein" | 19497413 |
| D019311 | Staurosporine | Staurosporine inhibits the reaction [Tretinoin results in increased phosphorylation of CDKN1B protein] | 16618747 |
| D013267 | Stilbenes | Stilbenes analog results in increased expression of CDKN1B mRNA | 25980588 |
| D013267 | Stilbenes | Stilbenes analog results in increased expression of CDKN1B protein | 25980588 |
| D013467 | Sulindac | Sulindac inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] | 12189186 |
| C025463 | sulindac sulfone | sulindac sulfone results in increased expression of CDKN1B mRNA | 18593937 |
| C025463 | sulindac sulfone | sulindac sulfone results in increased expression of CDKN1B protein | 18593937 |
| D014284 | Triiodothyronine | Triiodothyronine results in decreased expression of CDKN1B protein | 16021636 |
| D014284 | Triiodothyronine | THRB protein promotes the reaction [Triiodothyronine results in decreased expression of CDKN1B protein] | 20638743 |
| D014284 | Triiodothyronine | Triiodothyronine results in decreased expression of CDKN1B protein | 20638743 |
| D014284 | Triiodothyronine | Triiodothyronine results in decreased expression of CDKN1B mRNA | 16021636 |
| D014284 | Triiodothyronine | Triiodothyronine results in decreased expression of CDKN1B protein | 16021636 |
| C112689 | TAC 101 | TAC 101 results in increased expression of CDKN1B mRNA | 10225456 |
| C112689 | TAC 101 | TAC 101 results in increased expression of CDKN1B protein | 10225456 |
| D016559 | Tacrolimus | Tacrolimus results in increased expression of CDKN1B mRNA | 21865292 |
| C467766 | taiwanin C | taiwanin C results in increased expression of CDKN1B protein | 26537528 |
| C467766 | taiwanin C | Tetradecanoylphorbol Acetate inhibits the reaction [taiwanin C results in increased expression of CDKN1B protein] | 26537528 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with FTI 277] promotes the reaction [CDKN1B protein binds to [CCNE1 protein binds to CDK2 protein]] | 12866041 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with tipifarnib] results in increased expression of CDKN1B protein | 17876043 |
| D013629 | Tamoxifen | Tamoxifen results in increased activity of CDKN1B protein | 15665275 |
| C021751 | tanshinone | indirubin promotes the reaction [tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein]] | 18344322 |
| C021751 | tanshinone | indirubin promotes the reaction [tanshinone results in increased expression of CDKN1B protein] | 18344322 |
| C021751 | tanshinone | tanshinone promotes the reaction [indirubin promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein]] | 18344322 |
| C021751 | tanshinone | tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein] | 18344322 |
| C021751 | tanshinone | tanshinone results in increased expression of CDKN1B protein | 18344322 |
| C021751 | tanshinone | tetraarsenic tetrasulfide promotes the reaction [indirubin promotes the reaction [tanshinone results in increased expression of CDKN1B protein]] | 18344322 |
| C047246 | temozolomide | [temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of CDKN1B protein | 20980775 |
| C047246 | temozolomide | [temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of CDKN1B protein | 20980775 |
| C041226 | Terazosin | Terazosin results in increased expression of CDKN1B protein | 12883741 |
| D016593 | Terfenadine | Terfenadine results in increased expression of CDKN1B protein | 12244568 |
| D013729 | Terpenes | Terpenes affects the phosphorylation of CDKN1B protein | 18281026 |
| D013739 | Testosterone | Testosterone results in decreased expression of CDKN1B mRNA | 15788153 |
| C534735 | tetraarsenic tetrasulfide | indirubin promotes the reaction [tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein]] | 18344322 |
| C534735 | tetraarsenic tetrasulfide | indirubin promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein] | 18344322 |
| C534735 | tetraarsenic tetrasulfide | tanshinone promotes the reaction [indirubin promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein]] | 18344322 |
| C534735 | tetraarsenic tetrasulfide | tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein] | 18344322 |
| C534735 | tetraarsenic tetrasulfide | tetraarsenic tetrasulfide promotes the reaction [indirubin promotes the reaction [tanshinone results in increased expression of CDKN1B protein]] | 18344322 |
| C534735 | tetraarsenic tetrasulfide | tetraarsenic tetrasulfide results in increased expression of CDKN1B protein | 18344322 |
| D013749 | Tetrachlorodibenzodioxin | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein] | 22266097 |
| D013749 | Tetrachlorodibenzodioxin | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] | 15157999 |
| D013749 | Tetrachlorodibenzodioxin | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CDKN1B protein | 9705214 |
| D013749 | Tetrachlorodibenzodioxin | Methoxsalen inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] | 15157999 |
| D013749 | Tetrachlorodibenzodioxin | Mifepristone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein] | 22266097 |
| D013749 | Tetrachlorodibenzodioxin | PGR protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein] | 22266097 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of and results in decreased activity of CDKN1B protein | 22266097 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein | 15157999 |
| D013749 | Tetrachlorodibenzodioxin | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] | 24013123 |
| D013749 | Tetrachlorodibenzodioxin | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] | 24013123 |
| D013749 | Tetrachlorodibenzodioxin | AHR affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA] | 21995607 |
| D013749 | Tetrachlorodibenzodioxin | CDKN1B protein affects the susceptibility to Tetrachlorodibenzodioxin | 20805476 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the localization of CDKN1B protein | 20805476 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of CDKN1B protein | 20486776 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with IGF1 protein] results in increased expression of CDKN1B protein | 20486776 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with SHH protein] results in increased expression of CDKN1B protein | 20486776 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in increased expression of CDKN1B mRNA | 25975270 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides affects the expression of CDKN1B protein] | 12883080 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of CDKN1B mRNA] | 12883080 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides results in increased expression of CDKN1B protein alternative form] | 12883080 |
| D013749 | Tetrachlorodibenzodioxin | "Tetrachlorodibenzodioxin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [CDK2 protein binds to CCNA2 protein binds to CDKN1B protein]]" | 20637255 |
| D013749 | Tetrachlorodibenzodioxin | "[Tetrachlorodibenzodioxin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [CDK2 protein binds to CCNA2 protein binds to CDKN1B protein]]] which results in decreased activity of CDK2 protein" | 20637255 |
| D013749 | Tetrachlorodibenzodioxin | "Tetrachlorodibenzodioxin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [CDK2 protein binds to CCNE1 protein binds to CDKN1B protein]]" | 20637255 |
| D013749 | Tetrachlorodibenzodioxin | "[Tetrachlorodibenzodioxin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [CDK2 protein binds to CCNE1 protein binds to CDKN1B protein]]] which results in decreased activity of CDK2 protein" | 20637255 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA | 10398686|1180433 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein | 10398686|1822710 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA | 20566336 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein | 14742689|2363962 |
| D013755 | Tetradecanoylphorbol Acetate | Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein]] | 12421932 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein | 12421932 |
| D013755 | Tetradecanoylphorbol Acetate | Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein] | 12421932 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [taiwanin C results in increased expression of CDKN1B protein] | 26537528 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CDKN1B mRNA | 25613284 |
| D013806 | Theophylline | [Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein | 21693435 |
| D013806 | Theophylline | sorafenib inhibits the reaction [[Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein] | 21693435 |
| D013806 | Theophylline | [Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein | 21693435 |
| D013853 | Thioacetamide | Thioacetamide affects the localization of CDKN1B protein | 22659510 |
| D013876 | Thiophenes | Thiophenes analog promotes the reaction [Tretinoin results in increased expression of CDKN1B protein] | 16140954 |
| D013893 | Thiram | Thiram results in decreased expression of CDKN1B mRNA | 20530235 |
| C402769 | tipifarnib | [Tamoxifen co-treated with tipifarnib] results in increased expression of CDKN1B protein | 17876043 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of CDKN1B protein | 27087172 |
| D014044 | Tolbutamide | Tolbutamide results in increased expression of CDKN1B protein | 16718685 |
| D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in decreased expression of CDKN1B mRNA | 25729387 |
| D019772 | Topotecan | Topotecan results in decreased expression of CDKN1B mRNA | 25729387 |
| D014212 | Tretinoin | Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein]] | 12421932 |
| D014212 | Tretinoin | Staurosporine inhibits the reaction [Tretinoin results in increased phosphorylation of CDKN1B protein] | 16618747 |
| D014212 | Tretinoin | Thiophenes analog promotes the reaction [Tretinoin results in increased expression of CDKN1B protein] | 16140954 |
| D014212 | Tretinoin | Tretinoin affects the expression of CDKN1B mRNA | 21924320 |
| D014212 | Tretinoin | Tretinoin affects the localization of CDKN1B protein | 16618747 |
| D014212 | Tretinoin | [Tretinoin co-treated with IFNG protein] results in increased expression of CDKN1B protein | 17960384 |
| D014212 | Tretinoin | Tretinoin inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in decreased expression of CDKN1B protein] | 11348869 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [Butyrates results in increased expression of CDKN1B mRNA] | 17431121 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [Butyrates results in increased expression of CDKN1B protein] | 17431121 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein] | 12421932 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [trichostatin A results in increased expression of CDKN1B mRNA] | 17431121 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [trichostatin A results in increased expression of CDKN1B protein] | 17431121 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [vorinostat results in increased expression of CDKN1B mRNA] | 17431121 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [vorinostat results in increased expression of CDKN1B protein] | 17431121 |
| D014212 | Tretinoin | Tretinoin results in increased expression of and results in decreased degradation of CDKN1B protein | 15695403 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CDKN1B | 11519864 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CDKN1B mRNA | 17349212|2372400 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CDKN1B protein | 11595732|1519442 |
| D014212 | Tretinoin | Tretinoin results in increased phosphorylation of CDKN1B protein | 16618747 |
| D014212 | Tretinoin | Tretinoin results in increased stability of CDKN1B protein | 11348869 |
| D014212 | Tretinoin | [Tretinoin results in increased ubiquitination of and results in increased degradation of SKP2 protein] which results in increased expression of CDKN1B protein | 11595732 |
| D014212 | Tretinoin | Tretinoin affects the localization of CDKN1B protein | 16618747 |
| D014212 | Tretinoin | Tretinoin results in increased phosphorylation of CDKN1B protein | 16618747 |
| C012589 | trichostatin A | [decitabine co-treated with trichostatin A] results in increased expression of CDKN1B mRNA | 17185465 |
| C012589 | trichostatin A | Tretinoin promotes the reaction [trichostatin A results in increased expression of CDKN1B mRNA] | 17431121 |
| C012589 | trichostatin A | Tretinoin promotes the reaction [trichostatin A results in increased expression of CDKN1B protein] | 17431121 |
| C012589 | trichostatin A | [trichostatin A affects the expression of DNMT3B protein] which affects the expression of CDKN1B mRNA | 18544619 |
| C012589 | trichostatin A | trichostatin A results in increased expression of CDKN1B mRNA | 17431121|2377000 |
| C012589 | trichostatin A | trichostatin A results in increased expression of CDKN1B protein | 17431121|2377000 |
| C080938 | tris(2-carboxyethyl)phosphine | tris(2-carboxyethyl)phosphine results in increased expression of CDKN1B protein | 18952254 |
| D014315 | Triterpenes | Triterpenes results in increased expression of CDKN1B mRNA | 18544911 |
| C057693 | troglitazone | CDKN1B protein affects the susceptibility to troglitazone | 11034103 |
| C057693 | troglitazone | [troglitazone binds to and results in increased activity of PPARG protein] which results in decreased degradation of CDKN1B protein | 14618613 |
| C057693 | troglitazone | [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of and results in increased ubiquitination of CDKN1B protein | 14618613 |
| C057693 | troglitazone | [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of CDKN1B protein | 11034103 |
| C057693 | troglitazone | [troglitazone co-treated with Aspirin] results in increased expression of CDKN1B protein | 19908241 |
| C057693 | troglitazone | troglitazone promotes the reaction [CDKN1B protein binds to CDK2 protein] | 12717389 |
| C057693 | troglitazone | troglitazone results in decreased expression of CDKN1B mRNA | 12680223 |
| C057693 | troglitazone | troglitazone results in decreased expression of CDKN1B protein | 12680223 |
| C057693 | troglitazone | troglitazone results in increased expression of CDKN1B mRNA | 17143939 |
| C057693 | troglitazone | troglitazone results in increased expression of CDKN1B protein | 11343236|1214914 |
| C057693 | troglitazone | [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein | 11318962 |
| C057693 | troglitazone | troglitazone results in decreased expression of CDKN1B protein | 11318962 |
| C113580 | U 0126 | "2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [U 0126 results in increased expression of CDKN1B protein]" | 22101421 |
| C113580 | U 0126 | "[U 0126 co-treated with 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] results in increased expression of CDKN1B protein" | 22101421 |
| C113580 | U 0126 | "U 0126 promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased expression of CDKN1B protein]" | 22101421 |
| C113580 | U 0126 | U 0126 results in increased expression of CDKN1B mRNA | 15930308 |
| C113580 | U 0126 | U 0126 results in increased expression of CDKN1B protein | 15930308|2210142 |
| D014520 | Urethane | Urethane results in decreased expression of CDKN1B mRNA | 12117781 |
| C005466 | ursolic acid | ursolic acid results in increased expression of CDKN1B protein | 24802810 |
| D014635 | Valproic Acid | Celecoxib promotes the reaction [Valproic Acid results in increased expression of CDKN1B protein] | 21737646 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of CDKN1B mRNA | 25979313 |
| D014635 | Valproic Acid | [Valproic Acid co-treated with Hydroxyurea] results in increased expression of CDKN1B mRNA | 17653085 |
| D014635 | Valproic Acid | Valproic Acid promotes the reaction [Celecoxib results in increased expression of CDKN1B protein] | 21737646 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of CDKN1B mRNA | 23179753|2800136 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of CDKN1B protein | 21737646 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of CDKN1B protein | 21708246 |
| D000068756 | Valsartan | Valsartan inhibits the reaction [AGT protein results in decreased expression of CDKN1B mRNA] | 19225232 |
| D014638 | Vanadates | AKT1 protein affects the reaction [Vanadates inhibits the reaction [chromium hexavalent ion affects the localization of CDKN1B protein]] | 19377290 |
| D014638 | Vanadates | Vanadates inhibits the reaction [chromium hexavalent ion results in decreased expression of and affects the localization of CDKN1B protein] | 19377290 |
| C066075 | vanadium pentoxide | vanadium pentoxide results in decreased expression of CDKN1B mRNA | 17459161 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CDKN1B mRNA | 23454527 |
| C551177 | vemurafenib | [(+)-JQ1 compound co-treated with vemurafenib] results in increased expression of CDKN1B protein | 27169980 |
| C017963 | vinyl carbamate | Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1B protein] | 12117777 |
| C017963 | vinyl carbamate | vinyl carbamate results in decreased expression of CDKN1B protein | 12117777 |
| D009536 | Niacinamide | Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] | 22561310 |
| D009536 | Niacinamide | Niacinamide results in increased expression of CDKN1B protein | 22561310 |
| D002762 | Cholecalciferol | Cholecalciferol promotes the reaction [CDKN1B protein binds to CDK2 protein] | 12907249 |
| D002762 | Cholecalciferol | Cholecalciferol results in increased expression of and results in decreased degradation of CDKN1B protein | 12907249 |
| D002762 | Cholecalciferol | Cholecalciferol results in increased expression of CDKN1B mRNA | 12907249 |
| D014810 | Vitamin E | Vitamin E results in increased expression of CDKN1B protein | 12352461 |
| D024483 | Vitamin K 3 | SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein] | 19082730 |
| D024483 | Vitamin K 3 | [sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein | 19082730 |
| C111237 | vorinostat | [Bortezomib co-treated with vorinostat] results in increased cleavage of CDKN1B protein | 15173093 |
| C111237 | vorinostat | Tretinoin promotes the reaction [vorinostat results in increased expression of CDKN1B mRNA] | 17431121 |
| C111237 | vorinostat | Tretinoin promotes the reaction [vorinostat results in increased expression of CDKN1B protein] | 17431121 |
| C111237 | vorinostat | [vorinostat co-treated with Bortezomib] results in increased expression of CDKN1B protein | 19220424 |
| C111237 | vorinostat | [vorinostat co-treated with Imatinib Mesylate] results in increased expression of CDKN1B protein | 12446442 |
| C111237 | vorinostat | vorinostat results in increased expression of CDKN1B mRNA | 17431121 |
| C111237 | vorinostat | vorinostat results in increased expression of CDKN1B protein | 12446442|1614494 |
| C085514 | wogonin | wogonin results in increased expression of CDKN1B protein | 23872260 |
| C085514 | wogonin | wogonin results in increased expression of CDKN1B protein | 23872260 |
| C009687 | wortmannin | wortmannin promotes the reaction [Doxorubicin results in increased expression of CDKN1B protein] | 17935137 |
| C009687 | wortmannin | wortmannin promotes the reaction [Etoposide results in increased expression of CDKN1B protein] | 17935137 |
| C009687 | wortmannin | Imatinib Mesylate promotes the reaction [wortmannin results in increased expression of CDKN1B protein] | 17129604 |
| C009687 | wortmannin | wortmannin results in increased expression of CDKN1B protein | 17129604 |
| C108830 | Y 27632 | Y 27632 results in increased expression of CDKN1B mRNA | 20578043 |
| D015215 | Zidovudine | [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1B mRNA | 15784690 |
| D019345 | Zinc Acetate | [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CDKN1B mRNA | 16357179 |
| D019345 | Zinc Acetate | Zinc Acetate results in increased expression of CDKN1B mRNA | 16357179 |
| C016837 | zinc chloride | zinc chloride results in decreased expression of CDKN1B mRNA | 21540303 |
| C088658 | zoledronic acid | gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein] | 16322342 |
| C088658 | zoledronic acid | [zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein | 16322342 |
| C088658 | zoledronic acid | zoledronic acid promotes the reaction [CYR61 protein affects the expression of CDKN1B protein] | 19530242 |